Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.

NANot yet recruitingINTERVENTIONAL
Enrollment

4,500

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

November 30, 2040

Study Completion Date

November 30, 2040

Conditions
CrohnUlcerative Colitis (UC)IBD (Inflammatory Bowel Disease)
Interventions
OTHER

Blood, fecal, saliva

Blood, fecal and saliva samples

OTHER

intestinal content samples and biopsies

intestinal content samples and biopsies obtained per upper or lower gastrointestinal tract endoscopy

All Listed Sponsors
collaborator

Sorbonne University

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT07172945 - Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants. | Biotech Hunter | Biotech Hunter